Group items tagged

Overview: Become knowledgeable and understand the False Claims Act, Anti-Kickback Statute, Physician Self-Referral Law, Excluded Individuals and additional criminal/civil laws that may worsen the punishment if these laws are violated. Understand the criteria of each law, exceptions and how to identify an issue that requires mitigation. Why should you Attend: Are you able to distinguish with certainty an agreement, contract or activity that is permissible versus one that is not under our current healthcare laws and regulations? Do you have a contract organization system where reviews are done regularly and retained centrally? Do you conduct auditing and monitoring of potential high risk compliance areas related to fraud, waste and abuse? If you are uncertain or need additional guidance on recognizing potential violations of healthcare fraud, waste and abuse regulations and how to audit and monitor for non-compliance, this training is for you. Areas Covered in the Session: Define and describe elements of the Anti-kickback Statute, False Claims Act, Exclusionary Rule, Physician Self-Referral Law and potential penalties for violations Discuss exceptions and related criteria to the Physician Self-Referral Law and the Anti-Kickback Statute Identify common potential issues that may result in violations and how to avoid or mitigate them Provide examples on how to comply with the regulations Describe areas to audit, monitor and implement policies/procedures for compliance Who Will Benefit: Health care providers Revenue cycle management employees Coders, Billers Compliance officers Contract management Compliance and Internal Audit professionals Healthcare administrators Speaker Profile Gail Madison Brown is a registered nurse and an attorney with over 25 years of experience in health care. For the last 15 years she has focused on health care compliance and revenue cycle management operations. Gail's experience ranges from starting new compliance programs and making impr

Overview: This webinar will provide up to date information about what constitutes blood borne pathogens from infectious materials, as well as other potentially infectious materials. The webinar will provide answers about how to prevent exposures, deal with spills or exposures should they occur, and the how to recognize the hazards of blood borne pathogens. A thorough description of the types of infections of concern for blood borne pathogens, how one might be exposed, the differences between blood born infections and other potentially infectious materials, methods for dealing with potential exposures or spills, and the requirements from OSHA to protect workers from exposure or to track exposures if they occur. Areas Covered in the Session: Infectious materials Other potentially infectious materials Prophylactic techniques that might be available Use of personal protective equipment Policies and procedures required by OSHA to protect workers Who Will Benefit: Safety Professionals Administrators Lab Workers Those who might be exposed to blood borne pathogens Price : $139.00 Contact Info: MentorHealth Phone No: 1-800-385-1607 FaX: 302-288-6884 support@mentorhealth.com Event Link: http://www.mentorhealth.com/control/w_product/~product_id=800684LIVE/ http://www.mentorhealth.com/ LinkedIn Follow us - https://www.linkedin.com/company/mentorhealth Twitter Follow us - https://twitter.com/MentorHealth1 Facebook Like us- https://www.facebook.com/MentorHealth1

The US Food and Drug Administration (FDA) has issued a statement warning healthcare providers about potential complications in patients fitted with both programmable cerebrospinal fluid (CSF) shunt systems and certain magnetic hearing devices.

Metastatic osteosarcoma is one form of the disease osteoarthritis. It has been found that this disease occurs due to a problem with the cells in the spinal cord that are responsible for the proper function of the joints. The disease generally affects the aging group and those individuals suffering from other medical conditions like diabetes etc. The pain caused due to metastatic osteosarcoma can be so severe that it leads to tremendous disability to the affected person. Increasing drug pipeline for malignant bones and soft tissue cancer is expected to drive growth of the global metastatic osteosarcoma treatment market. Key biopharmaceutical and pharmaceutical companies are focused on research and development activities to synthesize novel drug treatment for soft tissue and malignant bone cancer. For instance, in September 2020, Junshi Biosciences, a major biopharmaceutical company, received the U.S. Food and Drug Administration (FDA) Orphan Drug designation to Toripalimab for the treatment of soft tissue sarcoma. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/metastatic-osteosarcoma-treatment.html

Pharmacovigilance, also called clinical pharmacology, is the clinical use of a drug in treating patients with certain disorders and diseases. Adverse drug events (ADRs), which include deaths from drug toxicity, can lead to severe medical consequences, as revealed in numerous studies about adverse drug reactions (ADR). To increase awareness about and educate patients about ADRs, more research in the area of ADRs and pharmacovigilance is required. In June 2020, the Food and Drug Administration (FDA) published a notice of intent to implement the National Pharmacy Ownership and Clinical Quality Improvement Organizations (NPHIA) guidelines on the regulation of pharmaceuticals and other medical products. The intention was to standardize the labeling and marketing of prescription and non-prescription drugs. The move resulted in the formation of the National Pharmacy Ownership and Clinical Quality Improvement Organizations (NPZA) and the National Institute for Drug Evaluation (NIDA). Although the new regulations established guidelines for the safe handling of pharmaceuticals, the problems still exist. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/how-pharmacovigilance-reduce-rate-of.html

Apheresis is an innovative medical procedure where the blood is extracted from the patient's body and then desired blood components (such as platelets, plasma, white cells, and red cells) are separated based on their weight and size. Depending on the cause of apheresis, one of these components is isolated and collected, while the other components are returned to the body. Apheresis is a blood purification procedure performed for blood donation component or for the treatment of disease. It is performed for various diseases such as hematological, autoimmune, renal, cardiovascular, neurological, and more. In apheresis procedure, the centrifuge therapeutic devices are used to separate desired blood components from the donor's blood. These blood components are separated based on their characteristics such as affinity for substance, molecular weight, and size among other factors. The emergence of COVID-19 is expected to propel the growth of the apheresis market. For instance, according to the Food and Drug Control Administration (Gujarat, India), there were 13 plasma apheresis units in the state before the pandemic, now the number has jumped to 28 to meet the requirement of plasma used in convalescent plasma therapy. Moreover, worldwide, as of 9:47am CET, 13 January 2021, there have been 90,054,813 confirmed cases of COVID-19, including 1,945,610 deaths, according to the World Health Organization (WHO). Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/emergence-of-covid-19-is-expected-to.html

Anti-suicide drugs are the most commonly used pharmaceuticals that are prescribed for the treatment of schizophrenia and other mood disorders. The U.S. Food and Drug Administration (FDA) approved these medications in 1970. They are usually called antipsychotic medications. Although they are very helpful in controlling both the mania and depression, this medicine can prove to be very dangerous if taken in high doses even without an anesthetic. These medications are meant for temporary use only, therefore, care should be taken when using it so as not to cause any harmful side effects on the patient's health. Hence, people who have other illnesses should avoid using these medications. Antidepressants such as Clomipramine and Anafranil (Anafranil or Elavil) are some of the most commonly prescribed medications in the treatment for acute and chronic pain. They are effective in relieving the patient's discomfort and can also help him to come up with his life. However, there are reported cases where patients have experienced severe side effects such as confusion, hallucinations, drowsiness, dizziness, agitation, insomnia, and pupil contraction. Some patients may also experience headache, upset stomach, nausea, and diarrhea. Although these medications are very effective, they also have a number of side effects on the patient's health such as irregular heartbeat, blurred vision, and chest pain. Medications such as Carbamazepine, Lamotrigine, and Phenytoin are also known anti-suicide drugs. These medications act in a different way from other types of drugs. They work by altering the protein structures of neurons in the brain. Because of this, the patient's level of consciousness also differs from the patient who takes conventional antidepressant medications. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/02/emergence-of-covid-19-increases-cases.html

Decline birth rate worldwide has led to the increasing adoption of various human reproductive technologies. For instance, according to the World Bank, Japan's birth rate, crude (per 1,000 people) decreased from 8.413 in 2005 to 7.4 in 2018. On the other hand, the increasing population has also led to the approval and launch of contraception products. In May 2020, Evofem Biosciences, Inc. received the U.S. Food and Drug Administration (FDA) approval for Phexxi (lactic acid, citric acid and potassium bitartrate) vaginal gel used to prevent pregnancy in females of reproductive potential for use as an on-demand method of contraception. As the use of human reproductive technologies advances, there is increasing concern about ethical issues surrounding these medical interventions. While the use of fertility medication has been approved by the FDA, there are still questions about how to regulate it because of the fact that it is not a prescription and because of the inherent risks associated with using the technology. The first thing that we need to recognize is that the technology of artificial insemination has been around for decades. The only difference today is that we now have the ability to use technology to assist in the process of getting pregnant. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/declining-birth-rate-and-increasing.html

Over-the-counter drugs (also known as non-prescription drugs) are drugs that one can buy without a prescription. These drugs are widely used to treat conditions that do not require direct consultation. Moreover, over-the-counter drugs are effective and safe when a consumer follows the instructions on the label or is provided by a doctor. The Food and Drug Administration in the United States considers when a specific drug is safe and effective enough to be sold over-the-counter. Over-the-counter drugs are widely used to treat symptoms of cold and flu worldwide. Several pharmaceutical manufacturers are focused on converting Rx (prescription drugs) to OTC (over-the-counter drugs) to meet the increasing demand. In the first half of 2019, Tachipirina was the best-selling non-prescription medication (over-the-counter drug) in Italian pharmacies. Rx to OTC switch is the transfer of proven prescription drugs to nonprescription. In February 2020, the FDA converted three prescription drugs to over-the-counter drugs, increasing access to the medicines. Moreover, many people worldwide prefer OTC drugs to treat minor illnesses before seeking professional care. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/over-counter-drugs-are-safe-and.html

The Trump administration announced that it will withhold $200 million in federal healthcare funding (including abortion) to California.

However, with a much-improved situation now, the government encourages private practices and clinics to resume their normal operations. They are to continue with their postponed non-emergency treatments and carry out in-person patient visits as we speak.

America should adopt smarter ways to counter COVID-19 as it reopens for patients and clinicians. In the meanwhile, CMS has come up with a guide for patients and beneficiaries as they decide to visit providers for in-person care.

Micro guide catheters are used in order to guide the urethra so that you can have an easy time inserting your pet's urethra and not be worried about any kind of blockage at all. There are many types of these devices available in the market. Some of these are manual tube and electric as well. Many people prefer to use micro guide catheters because they are made very simple and with great ease of use. A growing number of surgical procedures for treating cardiovascular diseases is fueling the growth of the micro guide catheters market. According to the American College of Cardiology Foundation, in 2017, emergency medical services-assessed out-of-hospital cardiac arrest occurred in an estimated 356,461 Americans; emergency medical services treatment was initiated in 52%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The increasing development of modern disposable catheters that are safer and more comfortable to insert is further projected to foster the growth of the micro guide catheters market. North America is projected to gain significant growth over the forecast period and this is attributed to the continuous launch of innovative products by ley players in the region. For instance, in March 2017, Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and the U.S. commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions Inc., which was acquired by Teleflex. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/rise-in-number-of-cardiovascular.html

Medical ceramics are ceramics that have the properties to be used as the direct medium of medical procedures. They are made from a number of different materials including porcelain, enamel, ceramic, polymers, and other materials. The ceramic material is used to serve the purpose of impregnating the substances on the affected part so that they get affected by the required heat and are changed into a non-toxic and safe substance. Increasing demand for implantable devices is expected to drive the growth of the global medical ceramics market. The demand for implantable devices offer additional advantages including the ability to selectively activate grouping of fibers within the nerve. Major companies operating in the market are focused on research and development activities, in order to gain a significant edge in the competition. For instance, in December 2020, W. L. Gore and Associates, Inc. received the U.S. Food and Drug Administration (FDA) approval for its Gore Excluder Comfortable (EXCC) AAA Endoprosthesis to treat patients with aneurysm of the infrarenal abdominal aorta. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/medical-ceramics-market-is-expanding.html

CMS issues a guideline for local and state authorities to ensure the phase-wise reopening of nursing homes, taking into consideration certain factors concerning the safety and protection of residents, staff, and visitors.

Chronic renal failure, or renal overload, is associated with a variety of morbidity and mortality and is a major challenge in the clinical treatment of patients with chronic renal failure. This disease has no cure and can be managed with specific medications in an appropriate course of therapy. However, in patients for whom other therapies have been ineffective or who are experiencing life-threatening side effects, continuous renal substitute therapy (CRS) is the only feasible treatment. Continuous Renal Replacement Therapy (CRRT) is a type of blood purification therapy used in the treatment of patients with acute kidney injury. The therapy is commonly used to provide renal support for critically ill patients with acute kidney injury, particularly patients who are hemodynamically unstable. Emergence of COVID-19 has led to increasing adoption of CRRT as patients with Covid-19 are experiencing multiple organ failure, including acute kidney injury. Moreover, regulatory bodies are also focused on approval and launch of new CRRT devices. For instance, in April 2020, The U.S. Food and Drug Administration granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms (or 5.5 to 22 pounds). Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/demand-for-continuous-renal-replacement.html

Endoscopy is a procedure that has been developed to assist in the removal of endometriosis from the human body. Endoscopy is also being used to help in the treatment of gallstones, cholecystitis, and gastric reflux disease among a number of other conditions. The recent developments in this industry have been driven by changes in government regulation and legislation. The increase in the number of malignancies and the introduction of fiscal policy in the region has resulted in political will on the part of the governments to strengthen public health services. Rising product approval for endoscopy devices by regulatory authorities is expected to drive growth of the global endoscopic stricture management device market during the forecast period. For instance, in January 2020, Pentax Medical received the U.S. Food and Drug Administration (FDA) approval for its Imagina Endoscopy System, which will be used in performing gastrointestinal procedures, digital image enhancement system with Pentax i-Scan. This endoscopy machine is equipped with an LED touch-screen interface, which removes the need for periodic bulb replacement. Besides, it is far more cost-efficient than the GI endoscopy system such as video endoscopy. Thus. These factors are expected to drive growth of the global endoscopic stricture management device market during the forecast period. Furthermore, increasing incidence of bleeding during surgical procedures combined with growing number of endoscopic procedures is expected to boost the global endoscopic stricture management device market growth over the forecast period. However, the lack of skilled healthcare professionals to perform surgical procedures, especially in emerging economies combined with complications related to endoscopic procedures such as bleeding and infection is expected to hamper the global endoscopic stricture management device market growth over the forecast period. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/end

Pharmaceutical drug prices are rising and contribute significantly to total health expenditure worldwide. Since 2014, prescription drug prices have increased by 33%. In 2020, global spending on prescription drugs is expected to be US$ 1.3 trillion. Increasing drug prices and consumer spending on prescription drugs are increasing the demand for the pharmacy benefit management system. The system is operated by third-party administrators who act as a link between drug manufacturers, insurance providers, and pharmacists. The system assists in reducing drug prices by negotiating with drug manufacturers and retail pharmacies. Those who are enrolled in various health schemes and those without insurance can get the benefit of the pharmacy benefit management system. The system provides medicines at a lower price than those available at retail pharmacies. To reduce rising health expenses, Japan planned to start reviewing drug prices every year instead of every two years. The move reflects growing resistance to rising drug prices worldwide. In Europe, different approaches have been implemented to regulate drug prices. In Germany, manufacturers can freely set the prices of newly developed drugs during their first year on the market. Benefit assessments are done during this year and then used in price negotiations between manufacturers and the country's representatives of statutory health insurers. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/pharmacy-benefit-management-is-integral.html

Drug delivery means different methods, approaches, technologies, formulations, and systems for transporting a pharmaceutical compound in the body to achieve desired therapeutic effects. There are different types of drug delivery including intravenous injectable, inhalation, or absorption. The injectable drug delivery is considered the most effective route of administration for the effective delivery of drugs to the targeted sites. This enhances the patient's compliance with the drug. This method of drug delivery boosts the drug adsorption from various sites including intravenous, subcutaneous, and intramuscular. Moreover, it increases the bioavailability of the drug at the systematic circulation of the drug at the designated site of action. The challenges of administering an injectable drug to an area are unique and complex. It is common practice to inject a small amount of a drug into the skin of a subject in order to administer a larger dose. However, many complications could occur if too much of a drug is injected at once. Since most of these systems are designed to administer large amounts over a long period of time, multiple injections could cause serious health problems, such as infection and damage to vital organs. The future injectable drug delivery will require the development of new methods for delivering medications, and the creation of new products that provide a safer, more effective environment for the delivery process. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/injectable-drug-delivery-is-getting.html

Abbott laboratories received the U.S. Food and Drug Administration (FDA) for its next-generation Influenza A & B2 and Strep A2 molecular assays. These assays are used for the molecular detection and differentiation of influenza A and B virus. Next-generation Influenza A & B2 and Strep A2 molecular assays are currently available on ID NOW platform, which is a rapid isothermal system. It is used for the detection of infectious diseases such as influenza.

Searching for reliable medical billing and insurance credentialing services in USA? Look no further! Our expert team offers top-notch solutions to streamline your billing and credentialing processes. Leave the administrative hassle to us and focus on providing excellent patient care.